Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Mallinckrodt
Colorcon
Boehringer Ingelheim
Dow

Last Updated: September 25, 2022

PROVENTIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Proventil, and what generic alternatives are available?

Proventil is a drug marketed by Schering and Kindeva and is included in six NDAs.

The generic ingredient in PROVENTIL is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Proventil

A generic version of PROVENTIL was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.

  Try it Free

Drug patent expirations by year for PROVENTIL
Drug Prices for PROVENTIL

See drug prices for PROVENTIL

Drug Sales Revenue Trends for PROVENTIL

See drug sales revenues for PROVENTIL

Recent Clinical Trials for PROVENTIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AstraZenecaPhase 2
University Medical Center of Southern NevadaN/A
West Penn Allegheny Health SystemPhase 4

See all PROVENTIL clinical trials

US Patents and Regulatory Information for PROVENTIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering PROVENTIL albuterol AEROSOL, METERED;INHALATION 017559-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-002 May 7, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol sulfate SYRUP;ORAL 018062-001 Jan 19, 1983 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Kindeva PROVENTIL-HFA albuterol sulfate AEROSOL, METERED;INHALATION 020503-001 Aug 15, 1996 AB1 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-002 Jan 14, 1987 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-001 Jan 14, 1987 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-001 May 7, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROVENTIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering PROVENTIL albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019383-001 Jul 13, 1987 See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-001 May 7, 1982 See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol AEROSOL, METERED;INHALATION 017559-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-001 Jan 14, 1987 See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-002 Jan 14, 1987 See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol sulfate TABLET;ORAL 017853-001 May 7, 1982 See Plans and Pricing See Plans and Pricing
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-002 Jan 14, 1987 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PROVENTIL

See the table below for patents covering PROVENTIL around the world.

Country Patent Number Title Estimated Expiration
Denmark 278575 See Plans and Pricing
Denmark 429375 See Plans and Pricing
Yugoslavia 34276 See Plans and Pricing
Yugoslavia 185367 See Plans and Pricing
Switzerland 583170 See Plans and Pricing
Malaysia 7500140 PHENYLAMINOETHANOL DERIVATIVES See Plans and Pricing
Belgium 752892 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Merck
Medtronic
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.